↓ Skip to main content

Diacerein for osteoarthritis

Overview of attention for article published in Cochrane database of systematic reviews, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
32 tweeters
facebook
4 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
198 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Diacerein for osteoarthritis
Published in
Cochrane database of systematic reviews, February 2014
DOI 10.1002/14651858.cd005117.pub3
Pubmed ID
Authors

Tania S.A. Fidelix, Cristiane R Macedo, Lara J Maxwell, Virginia Fernandes Moça Trevisani

Abstract

Osteoarthritis (OA) is one of the most prevalent musculoskeletal diseases. There is currently no consensus on what is the best treatment to improve OA symptoms and slow disease progression. Diacerein is an anthraquinone synthesised in 1980 that interferes with interleukin-1, an inflammatory mediator. It has been proposed that diacerein acts as a slow-acting, symptom-modifying and perhaps disease-structure-modifying drug for OA. This is an update of a Cochrane review first published in 2006.

Twitter Demographics

The data shown below were collected from the profiles of 32 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 198 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Netherlands 1 <1%
Romania 1 <1%
Unknown 195 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 33 17%
Researcher 32 16%
Student > Ph. D. Student 27 14%
Student > Bachelor 24 12%
Student > Doctoral Student 16 8%
Other 37 19%
Unknown 29 15%
Readers by discipline Count As %
Medicine and Dentistry 86 43%
Nursing and Health Professions 17 9%
Pharmacology, Toxicology and Pharmaceutical Science 14 7%
Agricultural and Biological Sciences 8 4%
Psychology 7 4%
Other 29 15%
Unknown 37 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2019.
All research outputs
#885,347
of 15,268,406 outputs
Outputs from Cochrane database of systematic reviews
#2,545
of 11,168 outputs
Outputs of similar age
#15,255
of 256,800 outputs
Outputs of similar age from Cochrane database of systematic reviews
#52
of 192 outputs
Altmetric has tracked 15,268,406 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,168 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.8. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 256,800 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 192 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.